By Jo Varshney
t’s been 10 months since the FDA declared a shortage of Adderall, a medication for the treatment of attention deficit hyperactivity disorder (ADHD) that is prescribed in brand name and generic-equivalent form to 41. 2 million people in the United States annually. While this isn’t the first Adderall shortage, it is quickly becoming




